In This Story ME -12.33% Genetic testing company 23andMe ( ME -12.33% ) filed for bankruptcy protection Sunday in the latest stage of a rocky road that included weak consumer demand and a 2023 data breach that jeopardized the genetic data of millions of customers. Suggested Reading GLP-1s are driving returns on R&D investments for Big Pharma, report says The Trump administration is being asked to relax some AI chip rules 6 most costly tornadoes to hit the U.S. Waymo is sending its robotaxis to